Summary of results of treatment of CD4 T cells with RNA expression constructs
| RNA . | Telomerase activity level . | Dexamethasone-induced apoptosis . | Stimulation-associated apoptosis . | hTERT-induced apoptosis . |
|---|---|---|---|---|
| shScramble | Normal | Susceptible | Normal | NA |
| shTERT | Decreased | Resistant | Normal | NA |
| shTR1,2 | Decreased | NA | Increased | NA |
| WT hTR | Increased | Susceptible | Normal | Susceptible |
| Δ96-97 | Catalytically inactive | NA | Normal | Resistant |
| G305A | Catalytically inactive | Resistant | Normal | Resistant |
| hTR-U64 | Catalytically inactive | Susceptible | Normal | Susceptible |
| hTERT | Increased | NA | Increased | NA |
| β−hTERT | Catalytically inactive | NA | Normal | NA |
| RNA . | Telomerase activity level . | Dexamethasone-induced apoptosis . | Stimulation-associated apoptosis . | hTERT-induced apoptosis . |
|---|---|---|---|---|
| shScramble | Normal | Susceptible | Normal | NA |
| shTERT | Decreased | Resistant | Normal | NA |
| shTR1,2 | Decreased | NA | Increased | NA |
| WT hTR | Increased | Susceptible | Normal | Susceptible |
| Δ96-97 | Catalytically inactive | NA | Normal | Resistant |
| G305A | Catalytically inactive | Resistant | Normal | Resistant |
| hTR-U64 | Catalytically inactive | Susceptible | Normal | Susceptible |
| hTERT | Increased | NA | Increased | NA |
| β−hTERT | Catalytically inactive | NA | Normal | NA |
NA, not analyzed. Bold text designates resistance to apoptosis. Italic text designates increased telomerase activity.